Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001445064-15-000072
Filing Date
2015-03-23
Accepted
2015-03-23 18:58:41
Documents
2
Period of Report
2015-03-19

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT edgar.html 4  
1 PRIMARY DOCUMENT edgar.xml 4 4685
2 KNEELAND C. YOUNGBLOOD POA youngbloodpoa.htm EX-24 4053
  Complete submission text file 0001445064-15-000072.txt   10051
Mailing Address C/O GAP, INC. 2 FOLSOM ST. SAN FRANCISCO CA 94105
Business Address
YOUNGBLOOD DR KNEELAND (Reporting) CIK: 0001137820 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35803 | Film No.: 15720190

Mailing Address DAMASTOWN MULHUDDART DUBLIN L2 15
Business Address DAMASTOWN MULHUDDART DUBLIN L2 15 353 1 8808180
Mallinckrodt plc (Issuer) CIK: 0001567892 (see all company filings)

EIN.: 981088325 | Fiscal Year End: 0930
SIC: 2834 Pharmaceutical Preparations